To analyze the survival related to therapeutic modalities and haematological indices at presentation with outcome performed on records of all multiple myeloma (MM) patients` Methods: A prospective study was conducted in the University of Benin Teaching Hospital, Nigeria from 1993 to2003. Thirty patients were identified with diagnosis confirmed on the basis of atypical plasmacytosis (=30% in the bone marrow), monoclonal component in the serum or urine and radiological evidence of the typical skeletal lytic lesions. Results: Males (n=20) out numbered the females (n=10), with a median age of 54 years. The mean duration of survival of all patients was 7months (median 3months; P